Author

M. L. Miller

Columbia UniversityORCID 0000-0002-6350-5706Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

M. L. Miller2 papers

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Carrie J. ShawberiD· 1 shared Claire Vanpouille‐BoxiD· 1 shared Darrell J. YamashiroiD· 1 shared Debarshi BanerjeeiD· 1 shared Eileen P. ConnollyiD· 1 shared Erin C. Connolly· 1 shared Michael Kissner· 1 shared Q. WangiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Carrie J. ShawberORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Novel Therapeutic Approach: Gamma Secretase Inhibitor Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment

Q. Wang, Debarshi Banerjee, Erin C. Connolly, Claire Vanpouille‐Box, Carrie J. Shawber, Rami Sesha Vanguri, Michael Kissner, M. L. Miller, Darrell J. Yamashiro, Eileen P. Connolly

This study shows that combining gamma secretase inhibitor with radiotherapy and checkpoint blockade therapy reprograms the tumor microenvironment to enhance antitumor immunity.

bioRxiv · Jun 1, 2026 · PreprintCancer Biology